Skip to main content
profile image
Selected Works of Walter J. Urba, MD, PhD
Article
Phase I study of safety and immunogenicity of ADU-623, a live-attenuated Listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRvIII and NY-ESO-1, in patients with WHO grade III/IV astrocytomas.
Journal of Clinical Oncology (2017)
  • Marka Crittenden, Providence Portland Medical Center
  • Keith S. Bahjat, Providence Portland Medical Center
  • Rui Li, Providence Portland Medical Center
  • Pankaj A. Gore
  • Chris Fountain
  • Bill Hanson, University of California, Berkeley
  • Justin Skoble, University of California, Berkeley
  • Peter Lauer, University of California, Berkeley
  • Aimee Murphy, University of California, Berkeley
  • Thomas Walter Dubensky, University of California, Berkeley
  • Dirk G. Brockstedt, Johns Hopkins University
  • Walter John Urba
Disciplines
Publication Date
January 31, 2017
Citation Information
Marka Crittenden, Keith S. Bahjat, Rui Li, Pankaj A. Gore, et al.. "Phase I study of safety and immunogenicity of ADU-623, a live-attenuated Listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRvIII and NY-ESO-1, in patients with WHO grade III/IV astrocytomas." Journal of Clinical Oncology (2017)
Available at: http://works.bepress.com/walter-urba/95/